Tumor microenvironment-responsive fenton nanocatalysts for intensified anticancer treatment

J Nanobiotechnology. 2022 Feb 5;20(1):69. doi: 10.1186/s12951-022-01278-z.

Abstract

Chemodynamic therapy (CDT) based on Fenton or Fenton-like reactions is an emerging cancer treatment that can both effectively fight cancer and reduce side effects on normal cells and tissues, and it has made important progress in cancer treatment. The catalytic efficiency of Fenton nanocatalysts(F-NCs) directly determines the anticancer effect of CDT. To learn more about this new type of therapy, this review summarizes the recent development of F-NCs that are responsive to tumor microenvironment (TME), and detailedly introduces their material design and action mechanism. Based on the deficiencies of them, some effective strategies to significantly improve the anticancer efficacy of F-NCs are highlighted, which mainly includes increasing the temperature and hydrogen peroxide concentration, reducing the pH, glutathione (GSH) content, and the dependence of F-NCs on acidic environment in the TME. It also discusses the differences between the effect of multi-mode therapy with external energy (light and ultrasound) and the single-mode therapy of CDT. Finally, the challenges encountered in the treatment process, the future development direction of F-NCs, and some suggestions are analyzed to promote CDT to enter the clinical stage in the near future.

Keywords: Cancer treatment; Fenton reaction; Multi-mode therapy; Nanocatalyst; Tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Catalysis
  • Cell Line, Tumor
  • Humans
  • Hydrogen Peroxide / chemistry
  • Nanoparticles* / chemistry
  • Neoplasms* / drug therapy
  • Tumor Microenvironment

Substances

  • Hydrogen Peroxide